Oramed Pharmaceuticals Inc.

ORMPNASDAQHealthcare● Active

$3.71

+$0.07(+1.92%)

Market Cap$151835761

P/E Ratio—

52W High$5.01

52W Low$1.98

Avg Volume155K

Open$3.66

Beta1.24

Net Income Financials Revenue

Oramed Pharmaceuticals Inc. (ORMP) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ORMP · net income · updated Jun 9, 2026

Core profitability metrics

ORMP · net income · margin · TTM · CAGR

Net income was $64.0M for FY2025 (fiscal year ending 2025-12-31), up 435.3% year-over-year. Net profit margin was 3202.5%. Based on available data, Oramed Pharmaceuticals Inc. has been profitable since at least 2023.

FY2025 Net Income$64.0M▲ +435.3% YoY

Trailing 12M (TTM)$110.0Mtrailing 4 quarters sum

Net Profit Margin> 999%$64.0M ÷ $2.0M

YoY Change+435.3%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2023

▸ FMP /income-statement · Annual · ORMP net income history · ORMP profit margin

Annual net income data

ORMP · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$64.0M▲ +435.3%3202.5%$2.0M

FY2024Loss−$19.1M▼ 445.8%—$0

FY2023★ First Profit$5.5M▲ +114.6%412.3%$1.3M

FY2022Loss−$37.8M▼ 69.8%-1397.1%$2.7M

FY2021Loss−$22.2M▼ 93.2%-822.7%$2.7M

Net income vs peers (Healthcare)

ORMP vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Oramed Pharmaceuticals Inc.YOU

ORMP

$64.0M+435.3%3202.5%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Oramed Pharmaceuticals Inc. (ORMP) reported net income of $64.0M for FY2025 (fiscal year ending 2025-12-31), up 435.3% year-over-year. The net profit margin was 3202.5% — meaning the company kept $32.02 of every dollar of revenue as profit.

Based on available data, Oramed Pharmaceuticals Inc. has been profitable since at least 2023. Net income reached a peak of $64.0M in FY2025. Data available for 15 fiscal years.

Oramed Pharmaceuticals Inc.'s net profit margin was 3202.5% for FY2025, based on the latest annual results.

Investors sometimes search for "Oramed Pharmaceuticals Inc. net worth" — the company's market capitalization is a separate figure from ORMP net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ORMP net income · 5 questions

Oramed Pharmaceuticals Inc. is profitable. The company reported net income of $64.0M for FY2025, a net profit margin of 3202.5%. Net income was up 435.3% year-over-year. Based on available data, Oramed Pharmaceuticals Inc. has been profitable since at least 2023.

is ORMP profitabledoes ORMP make a profitORMP profitabilityORMP profitable company

▸ Source: FMP /income-statement · GAAP · Oramed Pharmaceuticals Inc. · Oramed Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026